AAR Archives -

Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.

Saving the jewel in the crown of ‘UKplc’: Brexit’s impact on pharma

https://pharmaphorum.com/views-and-analysis/saving-jewel-crown-ukplc-brexits-impact-pharma/

What can the AAR do for the UK pharma industry, the health service and patients?

Accelerated Access Review: no panacea for UK pharma

https://pharmaphorum.com/views-and-analysis/accelerated-access-review-no-panacea-uk-pharma/

Barbara McLaughlan discusses England’s Cancer Drugs Fund (CDF) and suggests ways of securing a new, sustainable assessment and

Is the Cancer Drugs Fund beyond fixing?

https://pharmaphorum.com/views-and-analysis/is-the-cancer-drugs-fund-beyond-fixing/

AAR